We bring unparalleled chemical diversity to areas of highest unmet medical need with the team and tools to turn the resulting discoveries into viable, high-impact therapeutics.
Over the last three years, our platform has been validated by pharma partners, helping them increase the chemical diversity of their therapeutic leads, including in cancer and antibiotics. We are now focusing on the discovery and development of novel and differentiated payloads for oncology antibody drug conjugates (ADCs) and have payload programs in various stages of optimization and preclinical development.
Our approach, dubbed ATLANTIS™, unleashes cutting-edge computational algorithms on large, proprietary metabolomic and bioassay datasets to rapidly uncover key chemical …
No services posted yet
This data is part of our proprietary analytics report:
This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality